PH17073A - Prostaglandin composition - Google Patents

Prostaglandin composition

Info

Publication number
PH17073A
PH17073A PH26191A PH26191A PH17073A PH 17073 A PH17073 A PH 17073A PH 26191 A PH26191 A PH 26191A PH 26191 A PH26191 A PH 26191A PH 17073 A PH17073 A PH 17073A
Authority
PH
Philippines
Prior art keywords
prostaglandin
compositions
prostaglandin composition
dissolved
combinations
Prior art date
Application number
PH26191A
Other languages
English (en)
Inventor
Gallo-Torres Hugo Enrique
Navnit H Shah
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PH17073A publication Critical patent/PH17073A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/557Eicosanoids, e.g. leukotrienes or prostaglandins

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PH26191A 1980-10-09 1981-09-11 Prostaglandin composition PH17073A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/195,575 US4310543A (en) 1980-10-09 1980-10-09 Prostaglandin compositions

Publications (1)

Publication Number Publication Date
PH17073A true PH17073A (en) 1984-05-24

Family

ID=22721933

Family Applications (1)

Application Number Title Priority Date Filing Date
PH26191A PH17073A (en) 1980-10-09 1981-09-11 Prostaglandin composition

Country Status (13)

Country Link
US (1) US4310543A (https=)
EP (1) EP0049852B1 (https=)
JP (1) JPS5793911A (https=)
AT (1) ATE14981T1 (https=)
AU (1) AU547175B2 (https=)
CA (1) CA1176567A (https=)
DE (1) DE3171928D1 (https=)
DK (1) DK442881A (https=)
IE (1) IE51637B1 (https=)
IL (1) IL63960A (https=)
NZ (1) NZ198533A (https=)
PH (1) PH17073A (https=)
ZA (1) ZA816852B (https=)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1695783A (en) * 1982-07-19 1984-01-26 Syntex (U.S.A.) Inc. Encapsulated pge type compositions
US4431833A (en) * 1982-12-27 1984-02-14 American Cyanamid Company Prostaglandin and hydroxylated fatty acid ester formulations
FR2549371B1 (fr) * 1983-07-20 1985-09-13 Sanofi Sa Nouvelle composition pharmaceutique contenant de l'acide valproique ou un de ses sels
KR850700213A (ko) * 1984-02-08 1985-12-26 제이.데스몬드 다비스 아세트 아미노펜 젤라틴 캡슐
DE3438830A1 (de) * 1984-10-23 1986-04-30 Rentschler Arzneimittel Nifedipin enthaltende darreichungsform und verfahren zu ihrer herstellung
NO882653D0 (no) * 1988-06-15 1988-06-15 Apothekernes Lab Doseringsform.
US5208256A (en) * 1990-05-22 1993-05-04 R-Tech Ueno, Ltd. Treatment of ocular hypertension with a synergistic combination for ocular administration
GB2281697A (en) * 1993-09-14 1995-03-15 Euro Celtique Sa Laxative compositions in capsules
US6180666B1 (en) 1997-09-05 2001-01-30 Anmax, Inc. Use of gallic acid esters to increase bioavailability of orally administered pharmaceutical compounds
US5962522A (en) * 1997-09-05 1999-10-05 Avmax, Inc. Propyl gallate to increase bioavailability of orally administered pharmaceutical compounds
WO2001003695A1 (en) * 1999-07-13 2001-01-18 Avmax, Inc. Improvement of bioavailability with vitamin c fatty acid esters
KR100649860B1 (ko) * 2000-09-01 2006-11-24 주식회사종근당 알프로스타딜 경점막 및 경피흡수제제
CA2422031C (en) * 2000-09-13 2011-11-15 Santen Pharmaceutical Co., Ltd. Ophthalmic solutions comprising difluoroprostaglandin f2 alpha
WO2005011704A1 (ja) * 2003-07-31 2005-02-10 Santen Pharmaceutical Co., Ltd. プロスタグランジン含有製品
KR101152470B1 (ko) 2003-08-13 2012-06-01 바이오콘 리미티드 치료제용 마이크로-입자 지방산 염 고형 투약 제형
EP1675548A4 (en) * 2003-09-25 2008-08-13 Activbiotics Inc RIFALAZIL FORMULATIONS
US9993558B2 (en) 2004-10-01 2018-06-12 Ramscor, Inc. Sustained release eye drop formulations
US8541413B2 (en) * 2004-10-01 2013-09-24 Ramscor, Inc. Sustained release eye drop formulations
CN102526064A (zh) * 2004-12-09 2012-07-04 参天制药株式会社 含有分子内具有氟原子的前列腺素的制品
WO2006068266A1 (ja) * 2004-12-24 2006-06-29 Santen Pharmaceutical Co., Ltd. プロスタグランジンF2a誘導体含有製品
CA2651159A1 (en) * 2006-04-06 2007-10-18 Activbiotics Pharma Llc Pharmaceutical compositions and uses thereof
EP2327398A3 (en) 2007-07-19 2014-05-21 R-Tech Ueno, Ltd. Pharmaceutical composition comprising 11-deoxy-prostaglandin compound and method for stabilizing the compound
EP2214635A1 (en) * 2007-10-19 2010-08-11 Purdue Research Foundation Solid formulations of crystalline compounds

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2889252A (en) * 1956-05-14 1959-06-02 American Cyanamid Co Gelatin capsule containing hexylresorcinol and a lower polyalkylene glycol
ZA721937B (en) * 1971-10-22 1972-12-27 Upjohn Co Pharmaceutical preparations and uses thereof
CA1043259A (en) * 1972-12-08 1978-11-28 Geoffrey F. Thompson Medicament preparations and vehicles therefor
US3932634A (en) * 1973-06-28 1976-01-13 Pfizer Inc. High potency vitamin water dispersible formulations
US4052446A (en) * 1973-08-06 1977-10-04 Hoffmann-La Roche Inc. 11,16-substituted prostaglandins
JPS6019734B2 (ja) * 1977-05-12 1985-05-17 三共株式会社 安定なプロスタグランジンe類製剤の製法
JPS6046094B2 (ja) * 1977-06-01 1985-10-14 科研製薬株式会社 安定化されたプロスタグランジンe類粉末製剤
FI790043A7 (fi) * 1978-01-17 1979-07-18 Sandoz Ag Prostaglandiner innehaollande terapeutisk sammansaettning

Also Published As

Publication number Publication date
AU7606881A (en) 1982-04-22
EP0049852A3 (en) 1983-01-26
ATE14981T1 (de) 1985-09-15
JPH032848B2 (https=) 1991-01-17
JPS5793911A (en) 1982-06-11
EP0049852A2 (de) 1982-04-21
US4310543A (en) 1982-01-12
IL63960A (en) 1985-05-31
DK442881A (da) 1982-04-10
IE812354L (en) 1982-04-09
ZA816852B (en) 1982-09-29
EP0049852B1 (de) 1985-08-21
AU547175B2 (en) 1985-10-10
IE51637B1 (en) 1987-01-21
CA1176567A (en) 1984-10-23
IL63960A0 (en) 1981-12-31
NZ198533A (en) 1984-12-14
DE3171928D1 (en) 1985-09-26

Similar Documents

Publication Publication Date Title
PH17073A (en) Prostaglandin composition
DE3172223D1 (en) Edible, pharmaceutical compositions and processes for making thereof
PL318560A1 (en) Novel orally administered preparations containing cyclosporin of simple composition and high bioavailability
DE69321596D1 (de) Ester und kombinationen von einem organischen nitrat und einem salicyclat
IL56991A0 (en) 4-halo-3-oxoandrost-4-ene-17 -thiocarboxylic acid esters their preparation and pharmaceutical compositions containing them
EP0121321A3 (en) Pharmaceutical compositions
FR2321892A1 (fr) Preparations pharmaceutiques pour l'administration orale renfermant un ester-17b de nandrolone et nouveaux esters-17b de nandrolone
DE3364234D1 (en) Antiphlogistic/antipyretic/analgesic pharmaceutical compositions containing theophylline derivatives as active ingredient
ZA898331B (en) Pharmaceutical compositions
GB8812653D0 (en) Pharmaceutical composition based on high concentration esters of docosahexaenoic acid
DE3164338D1 (en) Conjugated polyprenylcarboxylic acids and their derivatives as well as pharmaceutical preparations containing these compounds
IL65922A0 (en) Preparation of apovincaminic acid esters,certain novel optically active derivatives thereof and pharmaceutical compositions containing them
DE2967551D1 (en) 5(6)-(2-amino-5-thiazoloyl)benzimidazole-2-carbamic acid esters and their salts, their preparation and use, and pharmaceutical compositions containing them
GB1321419A (en) Pharmaceutical composition
GB2122189B (en) Alpha-(n-pyrrolyl)-phenylacetic acids esters thereof their preparation pharmaceutical compositions containing them and therapeutical applications thereof
JPS52130905A (en) Medicinal composition
BE881625A (fr) Esters o-alcoxycarbonyl-phenyliques d'un acide anthranilique leur preparation et compositions pharmaceutiques en contenant
IL56487A (en) Quaternary salts of bis isoquinolinoalkyl benzene dicarboxylic acid esters,their preparation and pharmaceutical compositions containing them
JPS5764609A (en) Cyclophosphamide composition for rectal administration
IL57859A0 (en) Salts of benzene and thiophene-carbothioic acid 2-aminoalkl esters and pharmaceutical compositions containing them
IL58154A0 (en) 1-methyl-4-piperidinol esters their preparation and pharmaceutical compositions containing them
JPS55361A (en) Method of using thienoyl peroxide as drug and toiletary substance and pharmaceutical and toiletary composition containing it
AU529728B2 (en) Esters of arylpropionic acid derivatives, their preparation and pharmaceutical compositions containing them
JPS5251362A (en) Preparation of optically active pyrrolidine derivatives
IL60598A0 (en) Ester derivative of 5-acylindane-2-carboxylic acid and salts thereof and pharmaceutical compositions containing them